These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33174024)

  • 1. Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells.
    Zheng JM; Wang SS; Tian X; Che DJ
    Mol Med Rep; 2020 Dec; 22(6):5326-5338. PubMed ID: 33174024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.
    Gao S; Cui Z; Zhao MH
    J Am Soc Nephrol; 2022 Sep; 33(9):1742-1756. PubMed ID: 35777783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3a receptor blockade protects podocytes from injury in diabetic nephropathy.
    Morigi M; Perico L; Corna D; Locatelli M; Cassis P; Carminati CE; Bolognini S; Zoja C; Remuzzi G; Benigni A; Buelli S
    JCI Insight; 2020 Mar; 5(5):. PubMed ID: 32161193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease.
    Zhang L; Li W; Gong M; Zhang Z; Xue X; Mao J; Zhang H; Li S; Liu X; Wu F; Shi J; Fu G
    FASEB J; 2022 Jun; 36(6):e22332. PubMed ID: 35503088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice.
    Wang F; Zha WS; Zhang JX; Li SL; Wang H; Ye LP; Shen T; Wu CH; Zhu QX
    Toxicol Lett; 2014 Aug; 229(1):229-39. PubMed ID: 24974766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation.
    Wadhwa M; Prabhakar A; Anand JP; Ray K; Prasad D; Kumar B; Panjwani U
    Brain Behav Immun; 2019 Nov; 82():129-144. PubMed ID: 31408672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic Syndrome.
    Buelli S; Locatelli M; Carminati CE; Corna D; Cerullo D; Imberti B; Perico L; Brigotti M; Abbate M; Zoja C; Benigni A; Remuzzi G; Morigi M
    Cells; 2022 May; 11(11):. PubMed ID: 35681450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.
    Shu C; Zha H; Long H; Wang X; Yang F; Gao J; Hu C; Zhou L; Guo B; Zhu B
    J Exp Clin Cancer Res; 2020 Jan; 39(1):11. PubMed ID: 31931851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma.
    Suzuki R; Okubo Y; Takagi T; Sugimoto M; Sato Y; Irie H; Nakamura J; Takasumi M; Kato T; Hashimoto M; Kobashi R; Hikichi T; Ohira H
    Anticancer Res; 2022 Mar; 42(3):1207-1215. PubMed ID: 35220210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.
    Ratajczak J; Reca R; Kucia M; Majka M; Allendorf DJ; Baran JT; Janowska-Wieczorek A; Wetsel RA; Ross GD; Ratajczak MZ
    Blood; 2004 Mar; 103(6):2071-8. PubMed ID: 14604969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Complement C3a
    Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J
    J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases.
    Guo Q; Subramanian H; Gupta K; Ali H
    PLoS One; 2011; 6(7):e22559. PubMed ID: 21799898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C3a receptor antagonist SB 290157 has agonist activity.
    Mathieu MC; Sawyer N; Greig GM; Hamel M; Kargman S; Ducharme Y; Lau CK; Friesen RW; O'Neill GP; Gervais FG; Therien AG
    Immunol Lett; 2005 Sep; 100(2):139-45. PubMed ID: 16154494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Complement C3a and C3a Receptor Pathway in Kidney Diseases.
    Gao S; Cui Z; Zhao MH
    Front Immunol; 2020; 11():1875. PubMed ID: 32973774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factors AP-1 and Ets are regulators of C3a receptor expression.
    Schaefer M; Konrad S; Thalmann J; Rheinheimer C; Johswich K; Sohns B; Klos A
    J Biol Chem; 2005 Dec; 280(51):42113-23. PubMed ID: 16253992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
    Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
    J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Complement C3a Receptor in Stroke.
    Ahmad S; Bhatia K; Kindelin A; Ducruet AF
    Neuromolecular Med; 2019 Dec; 21(4):467-473. PubMed ID: 31102134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
    Proctor LM; Moore TA; Monk PN; Sanderson SD; Taylor SM; Woodruff TM
    Int Immunopharmacol; 2009 Jun; 9(6):800-6. PubMed ID: 19285573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.